Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hannah Burke (Southampton, United Kingdom), Hannah Burke, C. Mirella Spalluto, Doriana Cellura, Karl J. Staples, Tom M.A. Wilkinson. Role of exosomal microRNA in driving skeletal muscle wasting in COPD. Eur Respir J 2015; 46: Suppl. 59, 2930

Member's Comments

No comment yet.

Related content which might interest you: Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Peripheral muscle mitophagy is enhanced in patients with COPD Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 The key role of microRNA-34a in the reduction of sirtuin-1 in COPD Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Investigating mitochondrial dysfunction in asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Involvement of ferroptosis in COPD pathogenesis Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Reactive oxygen species regulate autophagy in COPD myotubes in vitro Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Cultured satellite cells as a model for the study of muscle dysfunction in COPD Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture model Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Potential role of SPARC, a downstream mediator of TGF-b in chronic airways disease Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Impaired myogenesis in the quadriceps muscle of cachectic COPD patients Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function Year: 2014 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Effect of oxidative stress on mitochondrial function in airway smooth muscle (ASM) cells from COPD patients Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Mitochondrial functional alterations in COPD locomotor muscle are independent of cachexia and fiber type shift Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Klotho expression is reduced in COPD Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013 Mitochondrial membrane potential in the airway and skeletal muscle compartments of smokers with and without COPD Source: International Congress 2014 – Translational studies in COPD Year: 2014 p53 dysfunction increased mitochondrial biogenesis and bronchial smooth muscle cell proliferation in asthma Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes Source: International Congress 2016 – Mechanisms of disease Year: 2016